AU2016319292A1 - Use of interleukin 2 for treating spondyloarthritis - Google Patents

Use of interleukin 2 for treating spondyloarthritis Download PDF

Info

Publication number
AU2016319292A1
AU2016319292A1 AU2016319292A AU2016319292A AU2016319292A1 AU 2016319292 A1 AU2016319292 A1 AU 2016319292A1 AU 2016319292 A AU2016319292 A AU 2016319292A AU 2016319292 A AU2016319292 A AU 2016319292A AU 2016319292 A1 AU2016319292 A1 AU 2016319292A1
Authority
AU
Australia
Prior art keywords
interleukin
use according
spondyloarthritis
administered
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016319292A
Other languages
English (en)
Inventor
Francis Berenbaum
Patrice CACOUB
Bruno FAUTREL
David Klatzmann
Roberta LORENZON
Jérémie SELLAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iltoo Pharma
Assistance Publique Hopitaux de Paris APHP
Sorbonne Universite
Original Assignee
Iltoo Pharma
Assistance Publique Hopitaux de Paris APHP
Sorbonne Universite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iltoo Pharma, Assistance Publique Hopitaux de Paris APHP, Sorbonne Universite filed Critical Iltoo Pharma
Publication of AU2016319292A1 publication Critical patent/AU2016319292A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016319292A 2015-09-10 2016-09-09 Use of interleukin 2 for treating spondyloarthritis Abandoned AU2016319292A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306383 2015-09-10
EP15306383.9 2015-09-10
PCT/EP2016/071370 WO2017042370A1 (en) 2015-09-10 2016-09-09 Use of interleukin 2 for treating spondyloarthritis

Publications (1)

Publication Number Publication Date
AU2016319292A1 true AU2016319292A1 (en) 2018-04-12

Family

ID=54145708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016319292A Abandoned AU2016319292A1 (en) 2015-09-10 2016-09-09 Use of interleukin 2 for treating spondyloarthritis

Country Status (6)

Country Link
US (1) US20190060407A1 (enExample)
EP (1) EP3347036A1 (enExample)
JP (1) JP2018526459A (enExample)
AU (1) AU2016319292A1 (enExample)
CA (1) CA2997946A1 (enExample)
WO (1) WO2017042370A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020005041A (es) 2017-11-21 2020-10-12 Univ Leland Stanford Junior Agonistas parciales de interleucina-2.
US11534479B2 (en) 2018-02-16 2022-12-27 Iltoo Pharma Use of interleukin 2 for treating Sjögren's syndrome
WO2020007937A1 (en) * 2018-07-03 2020-01-09 Iltoo Pharma Use of interleukin-2 for treating systemic sclerosis
JP2021532155A (ja) * 2018-08-01 2021-11-25 タリス バイオメディカル エルエルシー トロスピウムを使用した過活動膀胱の治療方法
EP4090674A4 (en) 2020-01-14 2024-01-24 Synthekine, Inc. Biased il2 muteins methods and compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2683395T3 (pl) * 2011-03-11 2019-04-30 Assist Publique Hopitaux De Paris Zastosowanie małych dawek il-2 do leczenia cukrzycy typu 1
CN104189892A (zh) * 2014-08-22 2014-12-10 北京大学人民医院 低剂量白细胞介素2在免疫相关性疾病治疗中的应用

Also Published As

Publication number Publication date
CA2997946A1 (en) 2017-03-16
US20190060407A1 (en) 2019-02-28
EP3347036A1 (en) 2018-07-18
JP2018526459A (ja) 2018-09-13
WO2017042370A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
JP7561893B2 (ja) 自己免疫関連障害または炎症性障害の治療のための低用量ｉｌ－２の使用
US20190351023A1 (en) Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
AU2016319292A1 (en) Use of interleukin 2 for treating spondyloarthritis
US8389479B2 (en) Compositions and methods for treatment of multiple sclerosis
US11534479B2 (en) Use of interleukin 2 for treating Sjögren's syndrome
US4946674A (en) Process for treatment of rheumatic diseases
WO2022235758A1 (en) Methods of treatment of autoimmune disorders using ilt7 binding proteins
AU2025202777A1 (en) Methods for the treatment of psoriatic arthritis
US20180325931A1 (en) Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome
ES2309299T3 (es) Tratamiento de la artritis reumatoide usando imatinib.
Karanikolas et al. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
WO2020007937A1 (en) Use of interleukin-2 for treating systemic sclerosis
Opoka-Winiarska et al. Current indications for the use of Janus kinase inhibitors in the treatment of juvenile idiopathic arthritis
WO2007126847A2 (en) Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
CN117561076A (zh) 使用ilt7结合蛋白治疗自体免疫病症的方法
JP5699030B2 (ja) エタネルセプトを含む線維筋痛症の治療剤
EP4447995A1 (en) Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions
WO2000035472A2 (en) Cytokine combination therapy
WO2020172238A1 (en) A method for predicting and monitoring the efficacy of low-dose il-2 and hydroxychloroquine therapy in autoimmune diseases and its long-term use in autoimmune-related conditions
Galbizo et al. Chronic graft-versus-host disease
MEMON et al. EFFICACY OF CYCLOSPORINE IN 36 PATIENTS WITH RHEUMATOID ARTHRITIS
Williams et al. Chronic Graft-Versus-Host Disease.
HK1072192B (en) Treatment of rheumatoid arthritis using imatinib
AU2003231607A8 (en) Treatment of Kaposi's sarcoma with IL-12

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period